Structured Nutrition and Behavioral Changes While taking semaglutide, your reduced appetite naturally limited portion sizes and reduced cravings for ultra-processed foods
Assessment and history A structured history should aim to distinguish (a) true vaginal mucosal symptoms, (b) vulvar dermatologic disease, (c) urinary tract symptoms, and (d) sexual function/arousal issues
Discussion This study evaluated the association between semaglutide pretreatment and reproductive outcomes in women with overweight and obesity with infertility
In the eighth trial of the STEP program (for the Semaglutide Treatment Effect in People with obesity), researchers compared semaglutide directly to liraglutide in comparable doses.19 After 68 weeks, participants on liraglutide lost an average of 6.4% body weight, but those on semaglutide saw nearly triple that effect, losing an average of 15.8% of body weight
When Microdosing May Not Be Appropriate Microdosing is not appropriate when core safety or metabolic foundations have not been addressed
W., et al
